Kafrelsheikh University: Ischemia trials

The registry lists 10 Ischemia studies with Kafrelsheikh University as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 3 8Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ticagrelor Versus Cilostazol in Ischemic StrokeRecruitingNCT06561867Phase 3
• Ticagrelor Versus Cilostazol in Large-vessel Ischemic StrokeRecruitingNCT06202755Phase 3
• Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIARecruitingNCT06196047Phase 3
• Clopidogrel Versus Cilostazol in Ischemic StrokeCompletedNCT06242132Phase 3
• Citicoline in Ischemic Stroke, a Randomized TrialCompletedNCT06210646Phase 3
• Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb IschemiaActive, not recruitingNCT06127134Not applicable
• Ticagrelor Versus Clopidogrel in Large Vessel Ischemic StrokeCompletedNCT06120725Phase 3
• Predictors of AIS Unfavorable OutcomesCompletedNCT06058884Phase 4
• Ticagrelor Versus Clopidogrel in Ischemic StrokeCompletedNCT05553613Phase 3
• Ticagrelol Versus Aspirin in Ischemic StrokeCompletedNCT03884530Phase 3